Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PAPAVERINE HYDROCHLORIDE INJECTION USP 65 MG / 2 ML

PAPAVERINE HYDROCHLORIDE : 65 MG / 2 ML · DIN 00009881 · SANDOZ CANADA INCORPORATED

Health Canada status: MARKETED

What is PAPAVERINE HYDROCHLORIDE INJECTION USP?

PAPAVERINE HYDROCHLORIDE INJECTION USP 65 MG / 2 ML contains PAPAVERINE HYDROCHLORIDE : 65 MG / 2 ML. It is listed in the Health Canada Drug Product Database under DIN 00009881, held by SANDOZ CANADA INCORPORATED, supplied as LIQUID for SUBCUTANEOUS ; INTRAVENOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 20-Aug-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN00009881
Brand namePAPAVERINE HYDROCHLORIDE INJECTION USP
Generic / active ingredientPAPAVERINE HYDROCHLORIDE : 65 MG / 2 ML
ManufacturerSANDOZ CANADA INCORPORATED
Strength65 MG / 2 ML
Dosage formLIQUID
Route of administrationSUBCUTANEOUS ; INTRAVENOUS ; INTRAMUSCULAR
ScheduleEthical
ATC codeA03AD01 PAPAVERINE
AHFS class24:12.92
BiosimilarNo
Health Canada statusMARKETED
Status date20-Aug-2005
Original market date1951-12-31 00:00:00

Who else supplies PAPAVERINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. PAPAVERINE appears in 3 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for PAPAVERINE HYDROCHLORIDE INJECTION USP

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for PAPAVERINE HYDROCHLORIDE INJECTION USP

Health Canada Drug Product Database (DPD), DIN 00009881. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.